The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Makashova N.V.

FGBU "NII glaznykh bolezneĭ" RAMN

Vasil'eva A.E.

GBOU VPO "Pervyĭ MGMU im. I.M. Sechenova" Minzdrava Rossii

Morozova N.E.

FGBU "Rossiĭskiĭ nauchnyĭ tsentr meditsinskoĭ reabilitatsii i kurortologii" Minzdrava Rossii

Ronzina I.A.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Application of Retinalamin for the treatment of glaucomatous optic neuropathy

Authors:

Makashova N.V., Vasil'eva A.E., Morozova N.E., Ronzina I.A.

More about the authors

Journal: Russian Annals of Ophthalmology. 2014;130(4): 71‑80

Read: 1586 times

Download PDF (RU)
Contact the author
Table of contents

APPLICATION OF RETINALAMIN FOR THE TREATMENT OF GLAUCOMATOUS OPTIC NEUROPATHY
APPLICATION OF RETINALAMIN FOR THE TREATMENT OF GLAUCOMATOUS OPTIC NEUROPATHY

To cite this article:

Makashova NV, Vasil'eva AE, Morozova NE, Ronzina IA. Application of Retinalamin for the treatment of glaucomatous optic neuropathy. Russian Annals of Ophthalmology. 2014;130(4):71‑80. (In Russ.)

Подписка 2026 Вестник офтальмологии (Russian Annals of Ophthalmology)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Obje­ctive stru­ctural and functional moni­toring of poly­peptide reti­nal neuroprotective therapy in diabetic reti­nopathy. Russian Annals of Ophthalmology. 2024;(5):97-104
Effi­cacy and safety of the fixed combination of dorzolamide/timolol (Dorzotimol) in primary open-angle glaucoma. Russian Annals of Ophthalmology. 2024;(5):125-129
The role of the stru­cture of the lamina cribrosa in the diagnosis and treatment of glaucoma. Stru­ctural and circulatory changes in the lamina cribrosa with aging and elevated intraocular pressure. Russian Annals of Ophthalmology. 2025;(1):76-82
Neuroprotective therapy of glaucoma. Russian Annals of Ophthalmology. 2025;(1):83-90
Modern approaches to combined surgery for cata­ract and primary open-angle glaucoma. Russian Annals of Ophthalmology. 2025;(3):92-99
Features of daily patterns of blood flow para­meters in the inte­rnal caro­tid arte­ries in primary open-angle glaucoma. Russian Annals of Ophthalmology. 2025;(5):66-71
The rela­tionship between neuropsychological indi­cators and neuroimaging changes acco­rding to MRI morphometry in patients with Alzheimer’s disease and glaucoma. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):142-152
Imme­diate resu­lts of medi­cine Slavinorm treatment in patients with athe­rosclerotic arte­ries diseases of the lower extremities. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):102-108
The author’s Time­less protocol: biostimulating peptides and pico­second alexandrite laser as an inno­vative approach to cellular reju­venation. Plastic Surgery and Aesthetic Medi­cine. 2025;(1):80-89
Abstract:

A case of Retinalamin (peptide-based drug) use in a patient with newly diagnosed glaucoma and therapeutically normalized intraocular pressure is reported. The results of visual field test (Humphrey Field Analyzer) and optic nerve examination (Heidelberg Retina Tomograph) as well as electrophysiological indices before and 1 and 3 month after the course of Retinalamin (10 parabulbar injections) are presented.

Keywords:

primary open-angle glaucoma
peptides
Retinalamin
visual fields
HRT
electrophysiological indices

Authors:

Makashova N.V.

FGBU "NII glaznykh bolezneĭ" RAMN

Vasil'eva A.E.

GBOU VPO "Pervyĭ MGMU im. I.M. Sechenova" Minzdrava Rossii

Morozova N.E.

FGBU "Rossiĭskiĭ nauchnyĭ tsentr meditsinskoĭ reabilitatsii i kurortologii" Minzdrava Rossii

Ronzina I.A.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Close metadata

References:

  1. Application of the drug retinalamin in Ophthalmology: A manual for physicians. St. Petersburg; 2005. 20 p. (In Russ.)
  2. Butin E.V. Otsenka neiroprotektornogo deistviya razlichnykh preparatov u bol'nykh s pervichnoi otkrytougol'noi glaukomoi: Avtoref. diss. kand. med. nauk [Evaluation of the neuroprotective effect of various drugs in patients with primary open-angle glaucoma: Cand. Diss. (Med. Sci.)]. St. Petersburg; 2010.
  3. Kurysheva N.I. Glaukomnaya opticheskaya neiropatiya [Glaucomatous optic neuropathy]. Moscow: MEDpress-inform Publ.; 2006. 136 p.
  4. Astakhov Yu.S. Evaluation of neuroprotective effect of retinalamine in treatment of patients with primary open-angle glaucoma. In: Retinalamin. Neiroprotektsiya v oftal'mologii [Retinalamin. Neuroprotection in ophthalmology]. St. Petersburg: Nauka Publ.; 2007: 38-46. (In Russ.)
  5. Rolik I.S. Osnovy klinicheskoi farmakologii organopreparatov [Clinical pharmacology basics of organic drugs]. Moscow: Regbiomed Publ.; 2004. 336 p.
  6. Dneprovskaya A.I., Kharintseva S.V. Effect of peptide from the retina on the state of hemostasis, immunity and course of experimental retinopathies. In: Kuznik B.I., ed. Tsitomediny [Cytomedines]. Chita; 1988: 35-36. (In Russ.)
  7. Shram S.I., Baibak A.V. Cytoprotective effect of cortexin and retinalamine on models of necrotic neuronal death caused by oxidative stress. In: D'yakonov M.M., Kamenskii A.A., eds. Peptidnaya neiroprotektsiya [Peptide neuroprotection]. St. Petersburg: Nauka Publ.; 2009: 10-20. (In Russ.)
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.